People who haven't had COVID will likely catch XBB.1.5 – and many will get reinfected, experts say |
mike kraft |
Group Post |
02/14/23 |
People With Dementia Are Twice as Likely to Get Covid--Study |
mike kraft |
Group Post |
02/09/21 |
People with HIV at higher risk of COVID reinfection -- CDC study |
mike kraft |
Group Post |
10/24/23 |
People with positive COVID results from home tests were 29% less likely to isolate |
mike kraft |
Group Post |
08/16/23 |
People with Type O blood may be less likely to get the coronavirus or develop severe complications-- new studies |
mike kraft |
Group Post |
10/16/20 |
People without symptoms spread virus in more than half of cases -- CDC model |
mike kraft |
Group Post |
01/08/21 |
People worldwide lost faith in childhood vaccines during COVID pandemic -- UNICEF survey |
mike kraft |
Group Post |
04/20/23 |
Persistent Viral Shedding of COVID-19 Is Associated with Delirium and Six-Month Mortality in Hospitalized COVID-19 Patients--new study |
mike kraft |
Group Post |
05/12/22 |
Personal beliefs may skew memories of COVID pandemic and deepen polarization--international studies |
mike kraft |
Group Post |
11/07/23 |
Persons at greatest COVID risk may not be getting the newest vaccines as outreach efforts drop |
mike kraft |
Group Post |
09/18/23 |
Persons disabled with covid-19 will need health care even after pandemic is over, public health expert says |
mike kraft |
Group Post |
03/09/21 |
Persons infected with COVID reinfections are likely to get reinfected within one or two years, models suggest propose |
mike kraft |
Group Post |
10/20/21 |
Persons who received a COVID vaccination after long COVID may have fewer severe symptoms--study |
mike kraft |
Group Post |
09/18/23 |
Peru pandemic death toll now worst in the world per capita |
mike kraft |
Group Post |
05/31/21 |
Pfizer and BioNTech announce plans to test omicron-specific COVID-19 vaccine in adult trials |
mike kraft |
Group Post |
01/25/22 |
Pfizer and BioNTech Omicron-targeted vaccine is delayed - |
mike kraft |
Group Post |
02/17/22 |
Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo |
mike kraft |
Group Post |
01/01/21 |
Pfizer and Clear Creek Bio partner to develop oral COVID-19 drug |
mike kraft |
Group Post |
12/06/22 |
Pfizer and Moderna are testing their vaccines against UK coronavirus variant |
mike kraft |
Group Post |
12/22/20 |
Pfizer and Moderna Covid-19 vaccines do not appear to pose serious risk during pregnancy--study |
mike kraft |
Group Post |
04/22/21 |
Pfizer and U.S. officials to discuss possible vaccine booster Monday |
mike kraft |
Group Post |
07/11/21 |
Pfizer Antiviral Pill To Treat Covid Could Be Ready By The End Of The Year--CEO |
mike kraft |
Group Post |
04/28/21 |
Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid |
mike kraft |
Group Post |
06/30/22 |
Pfizer asks U.S. FDA to clear updated COVID shot for kids under 5 |
mike kraft |
Group Post |
12/05/22 |
Pfizer asks US to allow COVID shots for kids ages 5 to 11 |
mike kraft |
Group Post |
10/07/21 |
Pfizer begins exporting to Mexico COVID-19 vaccine from its US plant |
mike kraft |
Group Post |
04/30/21 |
Pfizer begins study of oral drug for prevention of COVID-19 |
mike kraft |
Group Post |
09/27/21 |
Pfizer BioNTechvaccine shots have stronger antibody response than Sinovac-- Hong Kong study |
mike kraft |
Group Post |
06/19/21 |
Pfizer bivalent COVID-19 booster vaccine highly effective --Israeli study of over 65's |
mike kraft |
Group Post |
04/14/23 |
Pfizer CEO confident that its COVID-19 vaccine protects against more severe Delta variant |
mike kraft |
Group Post |
06/14/21 |
Pfizer CEO predicts 'constant waves' of COVID-19 because of complacency and politicization |
mike kraft |
Group Post |
05/25/22 |
Pfizer CEO predicts life will come back to normal within a year even with new coronavirus variants |
mike kraft |
Group Post |
09/27/21 |
Pfizer CEO says omicron vaccine will be ready in March |
mike kraft |
Group Post |
01/10/22 |
Pfizer CEO thinks Covid-19 vaccine will work against Omicron variant, but could offer less protection |
mike kraft |
Group Post |
11/29/21 |
Pfizer CEO: Third dose of COVID-19 vaccine 'likely' needed within 1 year |
mike kraft |
Group Post |
04/15/21 |
Pfizer CEO: ‘Disappointed’ in presidential debate, vows no political pressure on Covid vaccination shot |
mike kraft |
Group Post |
10/01/20 |
Pfizer COVID tracking confirms safety for kids, heart issues extremely rare. |
mike kraft |
Group Post |
05/26/23 |
Pfizer COVID-19 vaccine 90% effective at preventing hospitalization, but weakens in preventing milder infections --study |
mike kraft |
Group Post |
10/05/21 |
Pfizer COVID-19 vaccine safe, effective on adolescents in trial, companies say |
mike kraft |
Group Post |
03/31/21 |
Pfizer director says shots for kids under 5 delayed due to low number of Covid cases in trial |
mike kraft |
Group Post |
02/14/22 |
Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year |
mike kraft |
Group Post |
11/18/20 |
Pfizer hopes to submit vaccine data for children under 5 by early June |
mike kraft |
Group Post |
05/03/22 |
Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies; Donates Paxlovid to poorer countries i |
mike kraft |
Group Post |
09/07/22 |
Pfizer launches trial to test Covid pill in children |
mike kraft |
Group Post |
03/10/22 |
Pfizer more than doubles price of Covid-19 medication Paxlovid, shortages in poorer countries |
mike kraft |
Group Post |
10/19/23 |
Pfizer official expects updated COVID-19 vaccine data for kids under 5 by April |
mike kraft |
Group Post |
01/05/22 |
Pfizer plans to submit data on a 4th Covid shot to FDA |
mike kraft |
Group Post |
03/14/22 |
Pfizer reports its COVID-19 vaccine trial data shows long-term efficacy in adolescents |
mike kraft |
Group Post |
11/22/21 |
Pfizer requests emergency authorization for its oral antiviral COVID-19 treatment |
mike kraft |
Group Post |
11/16/21 |
Pfizer says booster in children 5-11 raises antibodies against omicron |
FNUOvviyaa |
Group Post |
04/14/22 |
Recent Comments